Home » TGA Panel Calls for Improved Transparency, Postmarket Process
TGA Panel Calls for Improved Transparency, Postmarket Process
August 2, 2011
Australia’s Therapeutic Goods Administration’s (TGA) transparency review panel is calling on the agency to take several steps toward greater transparency, including developing an early postmarket risk communication scheme and creating an online tracking system for applications.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor